KARFUNKEL SC 13D MAY 13 2009

Company

Lineage Cell Therapeutics, Inc.

Filed

May 22, 2009

Accession Number

0000876343-09-000030

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →